NSIM
NVAX icon

North Star Investment Management’s Novavax NVAX Stock Holding History

North Star Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22
Closed -$106 – 1259
2023
Q4 		$106 Hold
22
– – ﹤0.01% 1170
2023
Q3 		$159 Hold
22
– – ﹤0.01% 1247
2023
Q2 		$163 Hold
22
– – ﹤0.01% 1259
2023
Q1 		$152 Hold
22
– – ﹤0.01% 1274
2022
Q4 		$226 Hold
22
– – ﹤0.01% 1275
2022
Q3 		$0 Hold
22
– – ﹤0.01% 1166
2022
Q2 		$1K Hold
22
– – ﹤0.01% 1093
2022
Q1 		$2K Hold
22
– – ﹤0.01% 1059
2021
Q4 		$3K Buy
+22
New +$3.78K ﹤0.01% 1055

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

North Star Investment Management's NVAX Position: Q1 2024 in Review

North Star Investment Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 22 shares — an estimated $106 sold.

North Star Investment Management first reported a position in NVAX in Q4 2021 and held it in 9 quarters. The position peaked at $3K in Q4 2021. 202 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • North Star Investment Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • North Star Investment Management sold 22 Novavax shares in Q1 2024, an estimated $106.
  • North Star Investment Management first reported a position in Novavax in Q4 2021 and held it in 9 quarters.
  • North Star Investment Management's Novavax position peaked at $3K in Q4 2021.
  • 202 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on North Star Investment Management's 13F filing for Q1 2024, filed 30 Apr 2024.